Abstract
Proline is an amino acid with an essential role for primary metabolism and physiologic functions. Hyperprolinemia results from the deficiency of specific enzymes for proline catabolism, leading to tissue accumulation of this amino acid. Hyperprolinemic patients can present neurological symptoms and brain abnormalities, whose aetiopathogenesis is poorly understood. This review addresses some of the findings obtained, mainly from animal studies, indicating that high proline levels may be associated to neuropathophysiology of some disorders. In this context, it has been suggested that energy metabolism deficit, Na+,K+-ATPase, kinase creatine, oxidative stress, excitotoxicity, lipid content, as well as purinergic and cholinergic systems are involved in the effect of proline on brain damage and spatial memory deficit. The discussion focuses on the relatively low antioxidant defenses of the brain and the vulnerability of neural tissue to reactive species. This offers new perspectives for potential therapeutic strategies for this condition, which may include the early use of appropriate antioxidants as a novel adjuvant therapy, besides the usual treatment based on special diets poor in proline.
Similar content being viewed by others
References
Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci 32:19–29
Abidin I, Yargicoglu P, Agar A, Gumuslu S, Aydin S, Ozturk O, Sahin E (2004) The effect of chronic restraint stress on spatial learning and memory: relation to oxidant stress. Int J Neurosci 114:683–699
Adams E (1970) Metabolism of proline and of hydroxyproline. Int Rev Connect Tissue Res 5:1–91
Adams E, Frank L (1980) Metabolism of proline and the hydroxyprolines. Annu Rev Biochem 49:1005–1061
Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JL (1999) Adenosine triphosphate: established and potential clinical applications. Drugs 58:211–232
Aksenov M, Aksenova M, Butterfield DA, Markesbery WR (2000) Oxidative modification of creatine kinase BB in Alzheimer’s disease brain. J Neurochem 74:2520–2527
Allen CL, Bayraktutan U (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4:461–470
Anderson CM, Swanson RA (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32:1–14
Anderson AA, Ushakov DS, Ferenczi MA, Mori R, Martin P, Saffell JL (2008) Morphoregulation by acetylcholinesterase in fibroblasts and astrocytes. J Cell Physiol 215:82–100
Aperia A (2007) New roles for an old enzyme: Na+, K+-ATPase emerges as an interesting drug target. J Intern Med 261:44–52
Arendt T, Bruckner MK, Lange M, Bigl V (1992) Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer’s disease resemble embryonic development—a study of molecular forms. Neurochem Int 21:381–396
Attwell D (2000) Brain uptake of glutamate: food for thought. J Nutr 130:1023–1025
Azzi A, Stocker A (2000) Vitamin E: non-antioxidant roles. Prog Lipid Res 39:231–255
Baker KD, Skuse DH (2005) Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychiatry 186:115–120
Battastini A, Oliveira E, Moreira C, Bonan C, Sarkis J, Dias R (1995) Solubilization and characterization of an ATP diphosphohydrolase (EC 3.6.1.5.) from rat brain plasma membranes. Biochem Mol Biol Int 37:209–219
Bavaresco CS, Calcagnotto T, Tagliari B, Delwing D, Lamers ML, Wannmacher CM, Wajner M, Wyse AT (2003) Brain Na+, K+-ATPase inhibition induced by arginine administration is prevented by vitamins E and C. Neurochem Res 28:825–829
Bavaresco CS, Streck EL, Netto CA, Wyse AT (2005) Chronic hyperprolinemia provokes a memory deficit in the Morris water maze task. Metab Brain Dis 20:73–80
Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357–366
Beal MF (2000) Oxidative metabolism. Ann NY Acad Sci 924:164–169
Beal MF (2007) Mitochondria and neurodegeneration. Novartis Found Symp. 287, 183–92; discussion 192–6.
Behl C (2005) Oxidative stress in Alzheimer’s disease: implications for prevention and therapy. Subcell Biochem 38:65–78
Bickford PC, Gould T, Briederick L, Chadman K, Pollock A, Young D, Shukitt-Hale B, Joseph J (2000) Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res 866:211–217
Bohmer AE, Streck EL, Stefanello F, Wyse AT, Sarkis JJ (2004) NTPDase and 5′-nucleotidase activities in synaptosomes of hippocampus and serum of rats subjected to homocysteine administration. Neurochem Res 29:1381–1386
Bonan CD, Amaral OB, Rockenbach IC, Walz R, Battastini AM, Izquierdo I, Sarkis JJ (2000) Altered ATP hydrolysis induced by pentylenetetrazol kindling in rat brain synaptosomes. Neurochem Res 25:775–779
Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC (2006) Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112:358–404
Buettner GR (1993) The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 300:535–543
Burton GW, Wronska U, Stone L, Foster DO, Ingold KU (1990) Biokinetics of dietary RRR-alpha-tocopherol in the male guinea pig at three dietary levels of vitamin C and two levels of vitamin E. Evidence that vitamin C does not “spare” vitamin E in vivo. Lipids 25:199–210
Cantuti-Castelvetri I, Shukitt-Hale B, Joseph JA (2000) Neurobehavioral aspects of antioxidants in aging. Int J Dev Neurosci 18:367–381
Carr A, Frei B (1999) Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 13:1007–1024
Chan AS, Cheung MC, Law SC, Chan JH (2004) Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer 100:398–404
Chatton JY, Marquet P, Magistretti PJ (2000) A quantitative analysis of L-glutamate-regulated Na+ dynamics in mouse cortical astrocytes: implications for cellular bioenergetics. Eur J Neurosci 12:3843–3853
Chen Y, Swanson RA (2003) Astrocytes and brain injury. J Cereb Blood Flow Metab 23:137–149
Chen X, Wang X, O’Neill AF, Walsh D, Kendler KS (2004) Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry 9:962–967
Cherkin A, Eckardt MJ, Gerbrandt LK (1976) Memory: proline induces retrograde amnesia in chicks. Science 193:242–244
Cherkin A, Bennett EL, Davis JL (1981) Amnestic effect of L-proline does not depend upon inhibition of brain protein synthesis. Brain Res 223:455–458
Cohen SM, Nadler JV (1997a) Sodium-dependent proline and glutamate uptake by hippocampal synaptosomes during postnatal development. Brain Res Dev Brain Res 100:230–233
Cohen SM, Nadler JV (1997b) Proline-induced potentiation of glutamate transmission. Brain Res 761:271–282
Cristalli G, Camaioni E, Vittori S, Volpini R, Borea PA, Conti A, Dionisotti S, Ongini E, Monopoli A (1995) 2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5′-N-ethyluronamide as selective A2a adenosine receptor agonists. J Med Chem 38:1462–1472
Cummings JL (2000) The role of cholinergic agents in the management of behavioral disturbances in Alzheimer’s disease. Int J Neuropsychopharmacol 3:21–29
Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105
David S, Shoemaker M, Haley BE (1998) Abnormal properties of creatine kinase in Alzheimer’s disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning. Brain Res Mol Brain Res 54:276–287
Delwing D, Bavaresco CS, Wannmacher CM, Wajner M, Dutra-Filho CS, Wyse AT (2003) Proline induces oxidative stress in cerebral cortex of rats. Int J Dev Neurosci 21:105–110
Delwing D, Chiarani F, Bavaresco CS, Wannmacher CM, Wajner M, Dutra-Filho CS, Wyse AT (2005a) Protective effect of antioxidants on brain oxidative damage caused by proline administration. Neurosci Res 52:69–74
Delwing D, Chiarani F, Wannmacher CM, Wajner M, Wyse AT (2005b) Effect of hyperprolinemia on acetylcholinesterase and butyrylcholinesterase activities in rat. Amino Acids 28:305–308
Delwing D, Bavaresco CS, Monteiro SC, Matte C, Netto CA, Wyse AT (2006a) Alpha-tocopherol and ascorbic acid prevent memory deficits provoked by chronic hyperprolinemia in rats. Behav Brain Res 168:185–189
Delwing D, Sarkis JJ, Wyse AT (2006b) Proline induces alterations in nucleotide hydrolysis in rat blood serum. Mol Cell Biochem 292:139–144
Delwing D, Chiarani F, Kurek AG, Wyse AT (2007a) Proline reduces brain cytochrome c oxidase: prevention by antioxidants. Int J Dev Neurosci 25:17–22
Delwing D, Cornelio AR, Wajner M, Wannmacher CM, Wyse AT (2007b) Arginine administration reduces creatine kinase activity in rat cerebellum. Metab Brain Dis 22:13–23
Delwing D, Goncalves MC, Sarkis JJ, Wyse AT (2007c) NTPDase and 5′-nucleotidase activities of synaptosomes from hippocampus of rats subjected to hyperargininemia. Neurochem Res 32:1209–1216
Delwing D, Sanna RJ, Wofchuk S, Wyse AT (2007d) Proline promotes decrease in glutamate uptake in slices of cerebral cortex and hippocampus of rats. Life Sci 81:1645–1650
Delwing D, Sarkis JJ, Wyse AT (2007e) Proline induces alterations on nucleotide hydrolysis in synaptosomes from cerebral cortex of rats. Brain Res 1149:210–215
Di Rosa G, Pustorino G, Spano M, Campion D, Calabro M, Aguennouz M, Caccamo D, Legallic S, Sgro DL, Bonsignore M, Tortorella G (2008) Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. Psychiatr Genet 18:40–42
Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47–95
Dumont M, Lin MT, Beal MF (2010) Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer’s disease. J Alzheimers Dis 20(Suppl 2):S633–S643
Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287:3223–3229
Eppenberger ME, Eppenberger HM, Kaplan NO (1967) Evolution of creatine kinase. Nature 214:239–241
Erecinska M, Silver IA (1994) Ions and energy in mammalian brain. Prog Neurobiol 43:37–71
Ferreira GC, Tonin A, Schuck PF, Viegas CM, Ceolato PC, Latini A, Perry ML, Wyse AT, Dutra-Filho CS, Wannmacher CM, Vargas CR, Wajner M (2007) Evidence for a synergistic action of glutaric and 3-hydroxyglutaric acids disturbing rat brain energy metabolism. Int J Dev Neurosci 25:391–398
Ferreira AG, Lima DD, Delwing D, Mackedanz V, Tagliari B, Kolling J, Schuck PF, Wajner M, Wyse AT (2010) Proline impairs energy metabolism in cerebral cortex of young rats. Metab Brain Dis 25:161–168
Fine SE, Weissman A, Gerdes M, Pinto-Martin J, Zackai EH, McDonald-McGinn DM, Emanuel BS (2005) Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord 35:461–470
Fleming GA, Hagedorn CH, Granger AS, Phang JM (1984) Pyrroline-5-carboxylate in human plasma. Metabolism 33:739–742
Floyd RA (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222:236–245
Flynn MP, Martin MC, Moore PT, Stafford JA, Fleming GA, Phang JM (1989) Type II hyperprolinaemia in a pedigree of Irish travellers (nomads). Arch Dis Child 64:1699–1707
Franzon R, Lamers ML, Stefanello FM, Wannmacher CM, Wajner M, Wyse AT (2003) Evidence that oxidative stress is involved in the inhibitory effect of proline on Na+, K+-ATPase activity in synaptic plasma membrane of rat hippocampus. Int J Dev Neurosci 21:303–307
Frei B, Stocker R, England L, Ames BN (1990) Ascorbate: the most effective antioxidant in human blood plasma. Adv Exp Med Biol 264:155–163
Fremeau RT Jr, Caron MG, Blakely RD (1992) Molecular cloning and expression of a high affinity L-proline transporter expressed in putative glutamatergic pathways of rat brain. Neuron 8:915–926
Gade G, Auerswald L (2002) Beetles’ choice–proline for energy output: control by AKHs. Comp Biochem Physiol B Biochem Mol Biol 132:117–129
Gogos JA, Santha M, Takacs Z, Beck KD, Luine V, Lucas LR, Nadler JV, Karayiorgou M (1999) The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 21:434–439
Goldstein I, Levy T, Galili D, Ovadia H, Yirmiya R, Rosen H, Lichtstein D (2006) Involvement of Na+, K+-ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry 60:491–499
Grafius MA, Bond HE, Millar DB (1971) Acetylcholinesterase interaction with a lipoprotein matrix. Eur J Biochem 22:382–390
Grisar T (1984) Glial and neuronal Na+-K+ pump in epilepsy. Ann Neurol 16(Suppl):S128–S134
Hagedorn CH, Phang JM (1983) Transfer of reducing equivalents into mitochondria by the interconversions of proline and delta 1-pyrroline-5-carboxylate. Arch Biochem Biophys 225:95–101
Halliwell B (1996) Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem Soc Trans 24:1023–1027
Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–1658
Halliwell B, Gutteridge JM (1985) The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med 8:89–193
Halliwell B, Gutteridge JMC (2007) Cellular responses to oxidative stress: adaptation, damage, repair, senescence and death, Vol. Oxford University Press, New York
Hattori N, Kitagawa K, Higashida T, Yagyu K, Shimohama S, Wataya T, Perry G, Smith MA, Inagaki C (1998) CI-ATPase and Na+, K+-ATPase activities in Alzheimer’s disease brains. Neurosci Lett 254:141–144
Hayward DC, Delaney SJ, Campbell HD, Ghysen A, Benzer S, Kasprzak AB, Cotsell JN, Young IG, Miklos GL (1993) The sluggish-A gene of Drosophila melanogaster is expressed in the nervous system and encodes proline oxidase, a mitochondrial enzyme involved in glutamate biosynthesis. Proc Natl Acad Sci USA 90:2979–2983
Henderson VW, Watt L, Buckwalter JG (1996) Cognitive skills associated with estrogen replacement in women with Alzeimer’s disease. Psychoneuroendocrinology 21:421–430
Hiramatsu T, Cortiella J, Marchini JS, Chapman TE, Young VR (1994) Plasma proline and leucine kinetics: response to 4 wk with proline-free diets in young adults. Am J Clin Nutr 60:207–215
Hu CA, Bart Williams D, Zhaorigetu S, Khalil S, Wan G, Valle D (2008) Functional genomics and SNP analysis of human genes encoding proline metabolic enzymes. Amino Acids 35:655–664
Humbertclaude V, Rivier F, Roubertie A, Echenne B, Bellet H, Vallat C, Morin D (2001) Is hyperprolinemia type I actually a benign trait? Report of a case with severe neurologic involvement and vigabatrin intolerance. J Child Neurol 16:622–623
Jacquet H, Demily C, Houy E, Hecketsweiler B, Bou J, Raux G, Lerond J, Allio G, Haouzir S, Tillaux A, Bellegou C, Fouldrin G, Delamillieure P, Menard JF, Dollfus S, D’Amato T, Petit M, Thibaut F, Frebourg T, Campion D (2005) Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry 10:479–485
Jamme I, Petit E, Divoux D, Gerbi A, Maixent JM, Nouvelot A (1995) Modulation of mouse cerebral Na+, K+-ATPase activity by oxygen free radicals. Neuroreport 7:333–337
Johnson G, Moore SW (2000) Cholinesterases modulate cell adhesion in human neuroblastoma cells in vitro. Int J Dev Neurosci 18:781–790
Kanwar YS, Manaligod JR (1975) Leukemic urate nephropathy. Arch Pathol 99:467–472
Kapogiannis D, Mattson MP (2010) Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer’s disease. Lancet Neurol 10:187–198
Karayiorgou M, Gogos JA (2004) The molecular genetics of the 22q11-associated schizophrenia. Brain Res Mol Brain Res 132:95–104
Kelly FJ (1998) Use of antioxidants in the prevention and treatment of disease. J Int Fed Clin Chem 10:21–23
Kessler A, Costabeber E, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2003) Proline reduces creatine kinase activity in the brain cortex of rats. Neurochem Res 28:1175–1180
Kim J, Amante DJ, Moody JP, Edgerly CK, Bordiuk OL, Smith K, Matson SA, Matson WR, Scherzer CR, Rosas HD, Hersch SM, Ferrante RJ (2010) Reduced creatine kinase as a central and peripheral biomarker in Huntington’s disease. Biochim Biophys Acta 1802:673–681
Layer PG, Willbold E (1995) Novel functions of cholinesterases in development, physiology and disease. Prog Histochem Cytochem 29:1–94
Lee KW, Kim SJ, Park JB, Lee KJ (2011) Relationship between Depression Anxiety Stress Scale (DASS) and urinary hydroxyproline and proline concentrations in hospital workers. J Prev Med Public Health 44:9–13
Lees GJ (1993) Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience 54:287–322
Levy F (2009) Dopamine vs noradrenaline: inverted-U effects and ADHD theories. Aust N Z J Psychiatry 43:101–108
Li MY, Lee TW, Yim AP, Chen GG (2006) Function of PPARgamma and its ligands in lung cancer. Crit Rev Clin Lab Sci 43:183–202
Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787–795
Liu Y, Borchert GL, Donald SP, Surazynski A, Hu CA, Weydert CJ, Oberley LW, Phang JM (2005) MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis 26:1335–1342
Loaiza A, Porras OH, Barros LF (2003) Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J Neurosci 23:7337–7342
Lucas DR, Newhouse JP (1957) The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol 58:193–201
Mancuso M, Orsucci D, LoGerfo A, Calsolaro V, Siciliano G (2010) Clinical features and pathogenesis of Alzheimer’s disease: involvement of mitochondria and mitochondrial DNA. Adv Exp Med Biol 685:34–44
Maragakis NJ, Rothstein JD (2001) Glutamate transporters in neurologic disease. Arch Neurol 58:365–370
Matte C, Durigon E, Stefanello FM, Cipriani F, Wajner M, Wyse AT (2006) Folic acid pretreatment prevents the reduction of Na+, K+-ATPase and butyrylcholinesterase activities in rats subjected to acute hyperhomocysteinemia. Int J Dev Neurosci 24:3–8
Matte C, Mackedanz V, Stefanello FM, Scherer EB, Andreazza AC, Zanotto C, Moro AM, Garcia SC, Goncalves CA, Erdtmann B, Salvador M, Wyse AT (2009) Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in brain and blood of rats: protective effect of folic acid. Neurochem Int 54:7–13
McCay PB (1985) Vitamin E: interactions with free radicals and ascorbate. Annu Rev Nutr 5:323–340
Mecocci P (2004) Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum. J Alzheimers Dis 6:159–163
Meldrum BS (1994) The role of glutamate in epilepsy and other CNS disorders. Neurology 44:14–23
Micheu S, Crailsheim K, Leonhard B (2000) Importance of proline and other amino acids during honeybee flight–Apis mellifera carnica POLLMANN. Amino Acids 18:157–175
Mitsubuchi H, Nakamura K, Matsumoto S, Endo F (2008) Inborn errors of proline metabolism. J Nutr 138:2016–2020
Monteiro SC, Matte C, Bavaresco CS, Netto CA, Wyse AT (2005) Vitamins E and C pretreatment prevents ovariectomy-induced memory deficits in water maze. Neurobiol Learn Mem 84:192–199
Moreira JC, Wannmacher CM, Costa SM, Wajner M (1989) Effect of proline administration on rat behavior in aversive and nonaversive tasks. Pharmacol Biochem Behav 32:885–890
Muller DP, Goss-Sampson MA (1989) Role of vitamin E in neural tissue. Ann NY Acad Sci 570:146–155
Murali G, Panneerselvam KS, Panneerselvam C (2008) Age-associated alterations of lipofuscin, membrane-bound ATPases and intracellular calcium in cortex, striatum and hippocampus of rat brain: protective role of glutathione monoester. Int J Dev Neurosci 26:211–215
Nadler JV (1987) Sodium-dependent proline uptake in the rat hippocampal formation: association with ipsilateral-commissural projections of CA3 pyramidal cells. J Neurochem 49:1155–1160
Nadler JV, Bray SD, Evenson DA (1992) Autoradiographic localization of proline uptake in excitatory hippocampal pathways. Hippocampus 2:269–278
Nakamura T, Lipton SA (2010) Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies. Cell Calcium 47:190–197
Olney JW (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164:719–721
Oresic M, Tang J, Seppanen-Laakso T, Mattila I, Saarni SE, Saarni SI, Lonnqvist J, Sysi-Aho M, Hyotylainen T, Perala J, Suvisaari J (2011) Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med 3:19
Ozawa S, Kamiya H, Tsuzuki K (1998) Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 54:581–618
Pandhare J, Donald SP, Cooper SK, Phang JM (2009) Regulation and function of proline oxidase under nutrient stress. J Cell Biochem 107:759–768
Paterlini M, Zakharenko SS, Lai WS, Qin J, Zhang H, Mukai J, Westphal KG, Olivier B, Sulzer D, Pavlidis P, Siegelbaum SA, Karayiorgou M, Gogos JA (2005) Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci 8:1586–1594
Pavone L, Mollica F, Levy HL (1975) Asymptomatic type II hyperprolinaemia associated with hyperglycinaemia in three sibs. Arch Dis Child 50:637–641
Peker E, Oktar S, Ari M, Kozan R, Dogan M, Cagan E, Sogut S (2009) Nitric oxide, lipid peroxidation, and antioxidant enzyme levels in epileptic children using valproic acid. Brain Res 1297:194–197
Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91:10625–10629
Phang JM (1985) The regulatory functions of proline and pyrroline-5-carboxylic acid. Curr Top Cell Regul 25:91–132
Phang JM, Downing SJ, Yeh GC (1980) Linkage of the HMP pathway to ATP generation by the proline cycle. Biochem Biophys Res Commun 93:462–470
Phang JM, Hu CA, Valle D (2001) Disorders of proline and hydroxyproline metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. Vol. 3. McGraw-Hill, New York, pp 1821–1838
Phang JM, Donald SP, Pandhare J, Liu Y (2008a) The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids 35:681–690
Phang JM, Pandhare J, Zabirnyk O, Liu Y (2008b) PPARgamma and Proline Oxidase in Cancer. PPAR Res.
Piani D, Frei K, Pfister HW, Fontana A (1993) Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor. J Neuroimmunol 48:99–104
Pisani A, Martella G, Tscherter A, Costa C, Mercuri NB, Bernardi G, Shen J, Calabresi P (2006) Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+, K+ATPase. Neurobiol Dis 23:54–60
Plesner L (1995) Ecto-ATPases: identities and functions. Int Rev Cytol 158:141–214
Pontes ZL, Oliveira LS, Franzon R, Wajner M, Wannmacher CM, Wyse AT (2001) Inhibition of Na+, K+-ATPase activity from rat hippocampus by proline. Neurochem Res 26:1321–1326
Porras OH, Ruminot I, Loaiza A, Barros LF (2008) Na+ - Ca2+ cosignaling in the stimulation of the glucose transporter GLUT1 in cultured astrocytes. Glia 56:59–68
Ralevic V, Burnstock G (2003) Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 16:133–140
Rauchova H, Drahota Z, Koudelova J (1999) The role of membrane fluidity changes and thiobarbituric acid-reactive substances production in the inhibition of cerebral cortex Na+, K+-ATPase activity. Physiol Res 48:73–78
Reddy PH, Reddy TP (2011) Mitochondria as a therapeutic target for aging and neurodegenerative diseases. Curr Alzheimer Res.
Reddy PV, Rao KV, Norenberg MD (2008) The mitochondrial permeability transition, and oxidative and nitrosative stress in the mechanism of copper toxicity in cultured neurons and astrocytes. Lab Invest 88:816–830
Reis EA, Zugno AI, Franzon R, Tagliari B, Matte C, Lammers ML, Netto CA, Wyse AT (2002) Pretreatment with vitamins E and C prevent the impairment of memory caused by homocysteine administration in rats. Metab Brain Dis 17:211–217
Reis HJ, Guatimosim C, Paquet M, Santos M, Ribeiro FM, Kummer A, Schenatto G, Salgado JV, Vieira LB, Teixeira AL, Palotas A (2009) Neuro-transmitters in the central nervous system & their implication in learning and memory processes. Curr Med Chem 16:796–840
Renick SE, Kleven DT, Chan J, Stenius K, Milner TA, Pickel VM, Fremeau RT Jr (1999) The mammalian brain high-affinity L-proline transporter is enriched preferentially in synaptic vesicles in a subpopulation of excitatory nerve terminals in rat forebrain. J Neurosci 19:21–33
Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL (2009) Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 34:1021–1029
Rose CR, Ransom BR (1996) Intracellular sodium homeostasis in rat hippocampal astrocytes. J Physiol 491:291–305
Ross G, Dunn D, Jones ME (1978) Ornithine synthesis from glutamate in rat intestinal mucosa homogenates: evidence for the reduction of glutamate to gamma-glutamyl semialdehyde. Biochem Biophys Res Commun 85:140–147
Roussos P, Giakoumaki SG, Bitsios P (2009) A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects. Biol Psychiatry 65:1063–1070
Sandy MS, Di Monte D, Smith MT (1988) Relationships between intracellular vitamin E, lipid peroxidation, and chemical toxicity in hepatocytes. Toxicol Appl Pharmacol 93:288–297
Sarkis JJF, Battastini AMO, Oliveira EM, Frasseto SS, Dias RD (1995) ATP diphosphohydrolases: an overview. J Braz Assoc Adv Sci 47:131–136
Schafer IA, Scriver CR, Efron ML (1962) Familial hyperprolinemia, cerebral dysfunction and renal anomalies occuring in a family with hereditary nephropathy and deafness. N Engl J Med 267:51–60
Segovia G, Porras A, Del Arco A, Mora F (2001) Glutamatergic neurotransmission in aging: a critical perspective. Mech Ageing Dev 122:1–29
Sen CK, Khanna S, Roy S (2004) Tocotrienol: the natural vitamin E to defend the nervous system? Ann NY Acad Sci 1031:127–142
Seye CI, Yu N, Jain R, Kong Q, Minor T, Newton J, Erb L, Gonzalez FA, Weisman GA (2003) The P2Y2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J Biol Chem 278:24960–24965
Shanti ND, Shashikumar KC, Desai PV (2004) Influence of proline on rat brain activities of alanine aminotransferase, aspartate aminotransferase and acid phosphatase. Neurochem Res 29:2197–2206
Sharma KV, Bigbee JW (1998) Acetylcholinesterase antibody treatment results in neurite detachment and reduced outgrowth from cultured neurons: further evidence for a cell adhesive role for neuronal acetylcholinesterase. J Neurosci Res 53:454–464
Shprintzen RJ, Goldberg RB, Young D, Wolford L (1981) The velo-cardio-facial syndrome: a clinical and genetic analysis. Pediatrics 67:167–172
Silman I, Sussman JL (2005) Acetylcholinesterase: ‘classical’ and ‘non-classical’ functions and pharmacology. Curr Opin Pharmacol 5:293–302
Silva RH, Abilio VC, Takatsu AL, Kameda SR, Grassl C, Chehin AB, Medrano WA, Calzavara MB, Registro S, Andersen ML, Machado RB, Carvalho RC, Ribeiro Rde A, Tufik S, Frussa-Filho R (2004) Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacology 46:895–903
Simila S, Visakorpi JK (1967) Hyperprolinemia without renal disease. Acta Paediatr Scand (Suppl 177-122).
Smith RJ, Phang JM (1979) The importance of ornithine as a precursor for proline in mammalian cells. J Cell Physiol 98:475–481
Solaini G, Baracca A, Lenaz G, Sgarbi G (2010) Hypoxia and mitochondrial oxidative metabolism. Biochim Biophys Acta 1797:1171–1177
Soreq H, Seidman S (2001) Acetylcholinesterase–new roles for an old actor. Nat Rev Neurosci 2:294–302
Sorg O, Horn TF, Yu N, Gruol DL, Bloom FE (1997) Inhibition of astrocyte glutamate uptake by reactive oxygen species: role of antioxidant enzymes. Mol Med 3:431–440
Steinlin M, Boltshauser E, Steinmann B, Wichmann W, Niemeyer G (1989) Hyperprolinaemia type I and white matter disease: coincidence or causal relationship? Eur J Pediatr 149:40–42
Stocker R (1999) The ambivalence of vitamin E in atherogenesis. Trends Biochem Sci 24:219–223
Strecker HJ (1957) The interconversion of glutamic acid and proline. I. The formation of delta1-pyrroline-5-carboxylic acid from glutamic acid in Escherichia coli. J Biol Chem 225:825–834
Sullivan PG, Brown MR (2005) Mitochondrial aging and dysfunction in Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry 29:407–410
Szabados L, Savoure A (2010) Proline: a multifunctional amino acid. Trends Plant Sci 15:89–97
Takada T, Suzuki H (2010) Molecular mechanisms of membrane transport of vitamin E. Mol Nutr Food Res 54:616–622
Tan HY, Callicott JH, Weinberger DR (2009) Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms. Cogn Neuropsychiatry 14:277–298
Tomimoto H, Yamamoto K, Homburger HA, Yanagihara T (1993) Immunoelectron microscopic investigation of creatine kinase BB-isoenzyme after cerebral ischemia in gerbils. Acta Neuropathol 86:447–455
Traber MG, Packer L (1995) Vitamin E: beyond antioxidant function. Am J Clin Nutr 62:1501S–1509S
Traber MG, Sies H (1996) Vitamin E in humans: demand and delivery. Annu Rev Nutr 16:321–347
Valle D, Goodman SI, Applegarth DA, Shih VE, Phang JM (1976) Type II hyperprolinemia. Delta1-pyrroline-5-carboxylic acid dehydrogenase deficiency in cultured skin fibroblasts and circulating lymphocytes. J Clin Invest 58:598–603
Van Harreveld A, Fifkova E (1974) Involvement of glutamate in memory formation. Brain Res 81:455–467
Van Spronsen M, Hoogenraad CC (2010) Synapse pathology in psychiatric and neurologic disease. Curr Neurol Neurosci Rep 10:207–214
Vatassery GT (1998) Vitamin E and other endogenous antioxidants in the central nervous system. Geriatrics 53(Suppl 1):S25–S27
Vianna LP, Delwing D, Kurek AG, Breier AC, Kreutz F, Chiarani F, Stefanello FM, Wyse AT, Trindade VM (2008) Effects of chronic proline administration on lipid contents of rat brain. Int J Dev Neurosci 26:567–573
Vignini A, Nanetti L, Moroni C, Tanase L, Bartolini M, Luzzi S, Provinciali L, Mazzanti L (2007) Modifications of platelet from Alzheimer disease patients: a possible relation between membrane properties and NO metabolites. Neurobiol Aging 28:987–994
Volterra A, Trotti D, Tromba C, Floridi S, Racagni G (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 14:2924–2932
Vorstman JA, Morcus ME, Duijff SN, Klaassen PW, Heineman-de Boer JA, Beemer FA, Swaab H, Kahn RS, van Engeland H (2006) The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 45:1104–1113
Vorstman JA, Turetsky BI, Sijmens-Morcus ME, de Sain MG, Dorland B, Sprong M, Rappaport EF, Beemer FA, Emanuel BS, Kahn RS, van Engeland H, Kemner C (2009) Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology 34:739–746
Voutsinos-Porche B, Bonvento G, Tanaka K, Steiner P, Welker E, Chatton JY, Magistretti PJ, Pellerin L (2003) Glial glutamate transporters mediate a functional metabolic crosstalk between neurons and astrocytes in the mouse developing cortex. Neuron 37:275–286
Wajner A, Burger C, Dutra-Filho CS, Wajner M, de Souza Wyse AT, Wannmacher CM (2007) Synaptic plasma membrane Na+, K+ -ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex. Metab Brain Dis 22:77–88
Waldbaum S, Patel M (2010) Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res 88:23–45
Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359–407
Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM (1992) Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis. Biochem J 281:21–40
Wallimann T, Dolder M, Schlattner U, Eder M, Hornemann T, O’Gorman E, Ruck A, Brdiczka D (1998) Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology. Biofactors 8:229–234
Wengreen HJ, Munger RG, Corcoran CD, Zandi P, Hayden KM, Fotuhi M, Skoog I, Norton MC, Tschanz J, Breitner JC, Welsh-Bohmer KA (2007) Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J Nutr Health Aging 11:230–237
Wu G, Bazer FW, Burghardt RC, Johnson GA, Kim SW, Knabe DA, Li P, Li X, McKnight JR, Satterfield MC, Spencer TE (2010) Proline and hydroxyproline metabolism: implications for animal and human nutrition. Amino Acids.
Wyse AT, Sarkis JJ, Cunha-Filho JS, Teixeira MV, Schetinger MR, Wajner M, Milton C, Wannmacher D (1994) Effect of phenylalanine and its metabolites on ATP diphosphohydrolase activity in synaptosomes from rat cerebral cortex. Neurochem Res 19:1175–1180
Wyse AT, Sarkis JJ, Cunha-Filho JS, Teixeira MV, Schetinger MR, Wajner M, Wannmacher CM (1995) ATP diphosphohydrolase activity in synaptosomes from cerebral cortex of rats subjected to chemically induced phenylketonuria. Braz J Med Biol Res 28:643–649
Wyse ATS, Streck EL, Worm P, Wajner A, Ritter F, Netto CA (2000) Preconditioning prevents the inhibition of Na+, K+-ATPase activity after brain ischemia. Neurochem Res 25:971–975
Wyse AT, Zugno AI, Streck EL, Matte C, Calcagnotto T, Wannmacher CM, Wajner M (2002) Inhibition of Na+, K+-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem Res 27:1685–1689
Yeh GC, Phang JM (1988) Stimulation of phosphoribosyl pyrophosphate and purine nucleotide production by pyrroline 5-carboxylate in human erythrocytes. J Biol Chem 263:13083–13089
Young VR, El-Khoury A (1995) The notion of the nutritional essentiality of amino acids, revisited, with a note on the indispensable amino acid requirements in adults. In: Cynober L (ed) Amino acid metabolism and therapy in health and nutritional disease. Vol. CRC Press, New York, p 191
Zaidi SM, Banu N (2004) Antioxidant potential of vitamins A. E and C in modulating oxidative stress in rat brain. Clin Chim Acta 340:229–233
Zarkovic K (2003) 4-hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 24:293–303
Zeviani M, Carelli V (2007) Mitochondrial disorders. Curr Opin Neurol 20:564–571
Zhang XJ, Yang L, Zhao Q, Caen JP, He HY, Jin QH, Guo LH, Alemany M, Zhang LY, Shi YF (2002) Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death Differ 9:790–800
Zhang XL, Jiang B, Li ZB, Hao S, An LJ (2007) Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Pharmacol Biochem Behav 88:64–72
Zhang SF, Hennessey T, Yang L, Starkova NN, Beal MF, Starkov AA (2010) Impaired brain creatine kinase activity in Huntington’s Disease. Neurodegener Dis.
Zimmermann H (1992) 5′ nucleotidase: molecular structure and functional aspects. Biochem J 285:345–365
Zugno AI, Scherer EB, Mattos C, Ribeiro CA, Wannmacher CM, Wajner M, Wyse AT (2007) Evidence that the inhibitory effects of guanidinoacetate on the activities of the respiratory chain, Na+, K+-ATPase and creatine kinase can be differentially prevented by taurine and vitamins E and C administration in rat striatum in vivo. Biochim Biophys Acta 1772:563–569
Zugno AI, Valvassori SS, Scherer EB, Mattos C, Matte C, Ferreira CL, Rezin GT, Wyse AT, Quevedo J, Streck EL (2009) Na+, K+-ATPase activity in an animal model of mania. J Neural Transm 116:431–436
Acknowledgements
We dedicate this review to Dr. Clovis M.D. Wannmacher and Dr. Moacir Wajner, who were supervisors of the Master degree and of the PhD degree of Dr. Angela T.S. Wyse. Professor Wannmacher initiated work with Inborn Errors of Metabolism (IEM) in Brazil in 1970, after which Dr. Moacir Wajner and Dr. Roberto Giugliani were incorporated and an IEM group was created in 1998, the group of IEM of the Metabolism of Department of Biochemistry, ICBS, Federal University Federal of Rio Grande do Sul is formed by Professors Clovis Wannmacher, Moacir Wajner, Carlos S. Dutra-Filho and Angela T.S. Wyse.
We thank Luiz Eduardo Baggio Savio and Andréa Kurek Ferreira for figure designs.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wyse, A.T.S., Netto, C.A. Behavioral and neurochemical effects of proline. Metab Brain Dis 26, 159–172 (2011). https://doi.org/10.1007/s11011-011-9246-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-011-9246-x